NuvaRing® Lawsuit Update: $100 Million Settlement Will Be Fully Funded by August 2014

Roger Denton and Kristine Kraft, partners at Schlichter, Bogard & Denton, LLP and Co-Lead Counsel in the NuvaRing® Multidistrict Litigation, report that the

FDA Approves Insulin Inhalation Powder, Afrezza®

On June 27, 2014 the U.S. Food and Drug Administration (FDA) approved Afrezza, an insulin powder used to control blood sugar levels in patients with diabetes. Data shows that approximately 25.8 million people in the United States, 8.3% of the population, have diabetes.

Sterile Drug Products by Unique Pharmaceuticals Ltd.: Recall - Lack of Sterility Assurance

Voluntary Nationwide Recall of Tattoo Ink, Tattoo Needles, Tattoo kits Due to Microbial Contamination